🔎 Trials Near Me

Gara Jalqabaatti › Dhibee Gaddii Guddaa › New York › New York City

Qorannoo klinikaalii Dhibee Gaddii Guddaa New York City, NY keessatti

Qorannoo 36 Dhibee Gaddii Guddaa f New York City fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

Namoota walitti qabaa jiraSadarkaa 3
  • Adams Clinical Harlem, New York
  • New York State Psychiatric Institute, New York
Umuriin 18 hanga 85 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06793397

A Study of Brenipatide in Adult Participants With Major Depressive Disorder

Namoota walitti qabaa jiraSadarkaa 3
  • Adams Clinical Harlem, New York
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07412756

A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder

Namoota walitti qabaa jiraSadarkaa 3
  • Fieve Clinical Research Inc, New York
  • Adams Clinical Harlem, New York
  • Manhattan Behavioral Medicine, New York
Umuriin 18 hanga 74 · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT07573176

Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

Namoota walitti qabaa jiraSadarkaa 3
  • Manhattan Behavioral Medicine, New York
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT05850689

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

Namoota walitti qabaa jiraSadarkaa 3
  • Fieve Clinical Research Inc, New York
Umuriin 18 hanga 74 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06559306

A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)

Namoota walitti qabaa jiraSadarkaa 2
  • Ima Clinical Research - Nyc Midtown, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07621237

Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder

Namoota walitti qabaa jiraSadarkaa 3
  • Vanda Investigational Site, New York
  • Vanda Investigational Site, New York
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06830044

DBS for TRD With the Medtronic Percept PC

Namoota walitti qabaa jira
  • Icahn School of Medicine at Mount Sinai, Mount Sinai West, New York
Umuriin 25 hanga 70 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT05773755

Pattern Separation in Major Depressive Disorder

Namoota walitti qabaa jiraSadarkaa 1
  • New York State Psychiatric Institute (NYSPI), New York
Umuriin 18 hanga 50 · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT07139834

A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)

Namoota walitti qabaa jiraSadarkaa 2
  • Seaport Investigator Site, New York
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT07065240

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)

Namoota walitti qabaa jiraSadarkaa 3
  • Fieve Clinical Research, Inc., New York
  • IMA Clinical Research, New York
Umuriin 18 hanga 74 · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT07076407

A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression

Namoota walitti qabaa jiraSadarkaa 2
  • Draig Clinical Site, New York
  • Draig Clinical Site, New York
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT07610473

Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)

Namoota walitti qabaa jira
  • Mount Sinai Hospital, New York
Umuriin 22 hanga 70 · Saalaa hunda · Haaromfame 28-Hag-2026 · NCT06423430

A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression

Namoota walitti qabaa jiraSadarkaa 2
  • Draig Clinical Site, New York
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 26-Hag-2026 · NCT07300969

NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Namoota walitti qabaa jiraSadarkaa 3
  • Neurocrine Clinical Site, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Hag-2026 · NCT06911112

NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Namoota walitti qabaa jiraSadarkaa 3
  • Neurocrine Clinical Site, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Hag-2026 · NCT06963021

A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

Namoota walitti qabaa jiraSadarkaa 2
  • IMA Clinical Research - NYC Midtown, New York
  • IMA Clinical Research - NYC Uptown, New York
Umuriin 18 hanga 64 · Saalaa hunda · Haaromfame 27-Ado-2026 · NCT07115329

Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol

Namoota walitti qabaa jiraSadarkaa 3
  • Clinical Research Site, New York
  • Clinical Research Site, New York
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 24-Ado-2026 · NCT07484217

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Namoota walitti qabaa jiraSadarkaa 3
  • Neurocrine Clinical Site, New York
  • Neurocrine Clinical Site, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ado-2026 · NCT06966401

Feasibility of Home-Based Intermittent 60Hz Light Therapy for Major Depressive Disorder (MDD)

Namoota walitti qabaa jira
  • NYU Langone Health, New York
Umuriin 24 hanga 65 · Saalaa hunda · Haaromfame 29-Wax-2026 · NCT07111390

A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder

Namoota walitti qabaa jiraSadarkaa 2
  • Ima Clinical Research - Manhattan /ID# 278212, New York
  • Manhattan Behavioral Medicine /ID# 277910, New York
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 15-Wax-2026 · NCT07276997

tDCS: Sleep to Mood in Depression (S2M-D)

Namoota walitti qabaa jira
  • NYU Langone Health, New York
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 08-Wax-2026 · NCT07572526

Triage Survey for Psychiatry Research Eligibility

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Adams Clinical, Harlem, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Cam-2026 · NCT05800925

A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)

Namoota walitti qabaa jiraSadarkaa 2
  • The Medical Research Network, LLC, New York
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 11-Cam-2026 · NCT06524830

Aβ Dynamics in LLMD

Namoota walitti qabaa jiraSadarkaa 4
  • NYU Langone Health, New York
Umuriin 60 fi ol · Saalaa hunda · Haaromfame 06-Cam-2026 · NCT05004987

Maintenance rTMS for Depression (Maitr-De)

Namoota walitti qabaa jira
  • Weill Cornell Medicine, New York
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 29-Elb-2026 · NCT06938841

Neutralizing Interleukin (IL)-6

Namoota walitti qabaa jiraSadarkaa 2Hojjettoota fayyaa simatamoo
  • Icahn School of Medicine at Mount Sinai, New York
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 29-Elb-2026 · NCT07493317

Mindfulness-Based fMRI Neurofeedback for Depression

Namoota walitti qabaa jira
  • Columbia University Irving Medical Center, New York
Umuriin 13 hanga 18 · Saalaa hunda · Haaromfame 29-Elb-2026 · NCT05617495

Brain Changes During Social Reward Psychotherapy for Mid- and Late-Life Suicidality

Namoota walitti qabaa jira
  • Weill Cornell Medicine, New York
Umuriin 50 hanga 80 · Saalaa hunda · Haaromfame 27-Bit-2026 · NCT05925322

Biomarker-guided rTMS for Treatment Resistant Depression

Namoota walitti qabaa jiraSadarkaa 3
  • Weill Cornell Medicine, New York
Umuriin 22 hanga 65 · Saalaa hunda · Haaromfame 25-Gur-2026 · NCT04041479

Transcranial Near Infrared Radiation and Cerebral Blood Flow in Depression - R33

Namoota walitti qabaa jira
  • NYU Langone Health, New York
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 05-Gur-2026 · NCT05573074

Invasive Decoding and Stimulation of Altered Reward Computations in Depression Patients

Namoota walitti qabaa jira
  • Icahn School of Medicine at Mount Sinai, New York
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 25-Ful-2025 · NCT05239780

Ketamine-Assisted Psychotherapy (KAP) Compared to Ketamine Alone for the Treatment of Depression

Namoota walitti qabaa jiraSadarkaa 2
  • Icahn School of Medicine at Mount Sinai, New York
Umuriin 18 hanga 90 · Saalaa hunda · Haaromfame 15-Ado-2025 · NCT06559826

Neural Circuit Effects of Ketamine in Depression

Namoota walitti qabaa jiraSadarkaa 4Hojjettoota fayyaa simatamoo
  • Icahn School of Medicine at Mount Sinai, New York
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 03-Ado-2025 · NCT06213324

Psilocybin With Pimavanserin Compared to Psilocybin Alone for the Treatment of Major Depressive Disorder

Namoota walitti qabaa jiraSadarkaa 2
  • Icahn School of Medicine at Mount Sinai, Center for Psychedelic Therapy Research, New York
Umuriin 21 hanga 80 · Saalaa hunda · Haaromfame 14-Cam-2025 · NCT06592833

A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

Namoota walitti qabaa jiraSadarkaa 4
  • Clinical Research Site, New York
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 23-Ama-2025 · NCT06223880

Qorannoo Dhibee Gaddii Guddaa magaalota biroo keessatti

Qorannoo biroo New York City keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.